Breast Cancer HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal
Breast Cancer, HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal
13:41 EST 27 Nov 2018 |
SCRIP
Medicare proposed rule exposes Part D protected class drugs to threat of formulary exclusion if price increases exceed a certain...
More From BioPortfolio on "Breast Cancer, HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal"